Study Shows Path to 'Dialing Down' Autoimmunity without Compromising Immune Response
Scientists Solve 3D Structure of Protein that Guides the Immune System
Snapshot: Simone Mori



Of Note

High School Student Philanthropy Group Selects TSRI for Donation

The Scripps Research Institute (TSRI) has received an “investment” award from a group of Clairemont High School students in San Diego who participated in Main Street Philanthropy, a nationwide project to impact the lives of teenagers and young adults through meaningful, hands-on involvement in charitable giving and community service.                         

The students, members of the school’s Academy of Business, called themselves the “Trauma Troopers” and spent 10 weeks identifying nonprofit organizations aligned with their personal values. Through quantitative and qualitative evaluations of each group, the students determined TSRI would be the best steward of their $370.44 donation, earned from fundraising efforts and Main Street Philanthropy donors.

“Of those we considered, you rose to the top as one that would do a good job in ensuring that our investment would truly impact the causes we care about,” the students wrote.

For more information on donating to TSRI, see

27th Annual Frontiers in Chemistry Symposium: February 5

TSRI’s 27th Annual Frontiers in Chemistry Symposium at The Scripps Research Institute (TSRI), presenting four distinguished speakers on research covering diverse topics within the molecular sciences, will be held on Friday, February 5, from 1 to 5:30 PM.

Dale Boger, Richard and Alice Cramer Professor of Chemistry and chair of the TSRI Department of Chemistry, and Phil Baran, Darlene Shiley Chair in Chemistry at TSRI, will co-host the event.

Symposium speakers and their lectures include:

  • Peter Schultz, TSRI CEO and Scripps Family Chair Professor, “Synthesis at the Interface of Chemistry and Biology”
  • Nora Volkow, director of the National Institute on Drug Abuse at the National Institutes of Health, “The Chemistry of Drugs”
  • Suzanne Walker, professor of microbiology and immunobiology at Harvard University, “The Split Personality of Human O-GlcNAc Transferase”
  • Martin Edwards, vice president and head of La Jolla Oncology Medicinal Chemistry for Pfizer World Wide Research & Development, “Heterocycles and Medicinal Chemistry: The Importance of Innovative Synthesis”

Sponsors include Abbvie, Abide Therapeutics, ActivX, AstraZeneca, Bristol-Myers Squibb, Genentech, Genomics Institute of the Novartis Research Foundation, Incite, Janssen Pharmaceutical Companies, Merck, Lilly, Pfizer, Sigma Aldrich and Wuxi AppTech.

While symposium admittance is free, attendance is limited to 300. Directions to the event, which will be held at The Auditorium at TSRI, and parking details are available at the symposium website or by contacting Mishelle McClanahan-Shinn at or Ezra Salazar at or (858) 784-2400.

Send comments to: mikaono[at]